Effects of Aminoguanidine and vitamin C on collagen type IV in diabetic nephropathy rats

Endocrine

Volumn 39, Issue 3, 2011, Pages 251-258

  Li, Qiangxiang ^a,c   Ao, Xiang ^b   Du, Youhong ^c   Li, Yang ^d   Ou, Yangshi ^e   Gong, Raofeng ^c   Sun, Xuexiong ^c   Yang, Yi Xiang ^c   Wen, Gebo ^a  

^a UNIVERSITY OF SOUTH CHINA   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

^c Department of Orthopedics   (China)

^d Maternal and Child Health Hospital of Hunan Province   (China)

^e The Second People's Hospital of Guangdong Province   (China)

Author keywords

Aminoguanidine; Diabetic nephropathy; Type IV collagen; Vitamin C

Indexed keywords

AMINOGUANIDINE; ASCORBIC ACID; COLLAGEN; COLLAGEN TYPE 4; COLLAGEN TYPE 4 ALPHA1 CHAIN; CREATININE; GLUCOSE; HEMOGLOBIN; MESSENGER RNA; NITROGEN; UNCLASSIFIED DRUG; UREA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DIABETIC NEPHROPATHY; DOWN REGULATION; DRUG EFFECT; DRUG MECHANISM; GENE EXPRESSION REGULATION; GLUCOSE BLOOD LEVEL; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; RAT; RENAL PROTECTION; UREA NITROGEN BLOOD LEVEL; URINARY EXCRETION;

EID: 79959931975     PISSN: 1355008X     EISSN: 15590100     Source Type: Journal    
DOI: 10.1007/s12020-010-9419-0     Document Type: Article

References (19)

1. T. Umezono, M. Toyoda, M. Kato et al., Glomerular expression of CTGF, TGF-beta 1 and type IV collagen in diabetic nephropathy. J. Nephrol. 19(6), 751-757 (2006) (Pubitemid 46415980)
2. A. Ceriello, Hyperglycaemia the bridge between non-enzymatic glycation and oxidative stress in the pathogenesis of diabetic complications. Diabetes Nutr. Metab. 12, 42-46(1999) (Pubitemid 29435807)
3. Y. Guo, C. Zhou, J. Xu, The effects of Pueraria on the inhibition of nonenzymatic glycation and oxidation in kidneys of streptozocin-induced diabetic rats. Jiangsu Med. J. 29(4), 669-671 (2003)
4. H. H. Hsu, C. K. Chang, H. C. Su et al., Renal connective tissue growth factor induction in experimental diabetes is prevented by aminoguanidine. Endocrinology 143(12), 4907-4915 (2002)
5. M. A. Shamsi, A. Amin, E. Adeghate et al., Effect of vitamin C on liver and kidney functions in normal and diabetic rats. Ann. N. Y. Acad. Sci. 1084, 371-390(2006) (Pubitemid 47091964)
6. T. Soulis-Liparota, M. E. Cooper, M. Dunlop, G. Jerums, Retardation by aminoguanidine of development of development of albuminuria, mesangial expansion, and tissue fluorescence in streptozotocin-induced diabetic rat. Diabetes 40(10), 1328-1334 (1991)
7. M. Gembal, J. Druzynska, M. Kowalczyk, E. Przepiera, M. Cybal, W. Arendarczyk et al., The effect of ascorbic acid on protein glycation in streptozotocin diabetic rats. Diabetologia 37(7), 731 (1994) (Pubitemid 24210235)
8. V. Thallas-Bonke, M. T. Coughlan, L. A. Bach et al., Preservation of kidney function with combined inhibition of NADPH oxidase and angiotensin-converting enzyme in diabetic nephropathy. Am. J. Nephrol. 32(1), 73-82 (2010)
9. T. S. Ha, E. J. Hong, E. M. Ahn et al., Regulation of type IV collagen alpha chains of glomerular epithelial cells in diabetic conditions. J. Korean Med. Sci. 24(5), 837-843 (2009)
10. M. Murussi, N. Murussi, N. Campagnolo et al., Early detection of diabetic nephropathy. Arq. Bras. Endocrinol. Metabol. 52(3), 442-451 (2008)
11. Y. Guo, X. Wang, H. Tong, Change serum type IV collagen in diabetic nephropathy. Jiangsu Med. J. 6(8), 619-620 (2002)
12. H. Jun, Y. Liu, X. Liang, Clinical significance of determination of glycosylated hemoglobin in diabetic retinopathy patients. Chin. J. Pract. Ophthalmol. 19(10), 756-757 (2001)
13. M. P. Cohen, G. T. Lautenslager, E. Hud et al., Inhibiting albumin glycation attenuates dysregulation of VEGFR-1 and collagen IV subchain production and the development of renal insufficiency. Am. J. Physiol. Renal Physiol. 292(2), F789-F795 (2007) (Pubitemid 46220547)
14. S. Kang, S. Zhao, W. Zhao, L. Cui, Clinical observation on puerarin for diabetic nephropathy. Clin. Focus 17(8), 440-441 (2002)
15. K. C. Chang, C. D. Tseng, M. S. Wu et al., Aminoguanidine prevents arterial stiffening in a new rat model of type 2 diabetes. Eur. J. Clin. Investig. 36(8), 528-535 (2006)
16. P. Qian, S. Cheng, J. Guo et al., Effects of vitamin E and vitamin C on nonenzymatic glycation and peroxidation in experimental diabetic rats. Wei Sheng Yan Jiu 29(4), 226-228 (2000)
17. P. A. Craven, F. R. DeRubertis, V. E. Kagan et al., Effects of supplementation with vitamin C or E on albuminuria, glomerular TGF-beta, and glomerular size in diabetes. J. Am. Soc. Nephrol. 8(9), 1405-1414 (1997)
18. S. R. Maxwall, Thomasonh, D. sandler et al., Antioxidant, status inpatients with uncomplicated insulin-dependent and non-insulindependent diabetes mellitus. Eur. J. Clin. Investig. 27(7), 484 (1997)
19. G. R. Stoppa, M. Cesquini, E. A. Roman et al., Aminoguanidine prevented impairment of blood antioxidant system in insulindependent diabetic rats. Life Sci 78(12), 1352-1361 (2006) (Pubitemid 43199956)